Stay updated on Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.

Latest updates to the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.4.3 updated from v3.4.2.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAn entry for Gastric cancer and a link to the Genetic and Rare Diseases Information Center were added under Resources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check32 days agoChange DetectedThe page footer now displays Revision: v3.4.2. The notice about lapses in government funding and the related operating status update has been removed.SummaryDifference0.4%

- Check39 days agoChange DetectedAdded a site-wide notice about potential delays due to government funding lapse and NIH Clinical Center status. Updated page revision from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check47 days agoChange DetectedThe page now shows a glossary toggle and includes minor textual updates to QC status labels and version information (e.g., capitalization changes) with a new revision number v3.4.0 replacing v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check54 days agoChange DetectedMinor revision update: Revision v3.3.4 added and Revision v3.3.3 removed, with no changes to study content, eligibility criteria, or outcomes; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Periop Chemo & Pembrolizumab in Gastric Cancer Clinical Trial page.